Cent Eur J Public Health 2012, 20(4):276-281 | DOI: 10.21101/cejph.a3727

What Polish hospital healthcare workers and lay persons know about counterfeit medicine products?

Monika Binkowska-Bury1, Maja Wolan1, Paweł Januszewicz2, Artur Mazur1, Zbigniew E. Fijałek2
1 Institute of Nursing and Health Sciences, Medical Department, University of Rzeszow, Poland
2 National Medicines Institute, Warsaw, Poland

Aim: To report on Polish hospital health care workers' and lay persons' knowledge about counterfeit medicine products.

Materials and methods: Cross-sectional design was used. Two types of questionnaire survey about counterfeit medicine, separate for health care professionals and lay persons were completed by 201 physicians and nurses, and 450 adult Polish residents between October 2008 and January 2009.

Results: Physicians and nurses working in hospitals are more aware of counterfeit medicine than lay persons and more often notice the presence of drugs from unknown sources. Nearly 90% of physicians, 80% of nurses, and more than 40% of representatives of the lay persons had heard about the possibility of importing illegal medicine from Ukraine or China. The majority of medical workers does not know the procedure for reporting suspicious medicine and do not warn their patients against purchasing medicine from unknown sources.

Conclusions: Increase education of nurses and physicians about counterfeit medicine particularly including the procedure of reporting suspicious medicine from unknown sources. In practice, reinforce a role of nurses and physicians in warning their patients against purchasing medicine from unknown sources and educate them about possible health hazards and life risks.

Klíčová slova: counterfeit medicine, nurses, physicians, lay persons, hospital

Vloženo: 20. září 2011; Revidováno: 8. listopad 2012; Přijato: 8. listopad 2012; Zveřejněno: 1. prosinec 2012  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Binkowska-Bury M, Wolan M, Januszewicz P, Mazur A, Fijałek ZE. What Polish hospital healthcare workers and lay persons know about counterfeit medicine products? Cent Eur J Public Health. 2012;20(4):276-281. doi: 10.21101/cejph.a3727. PubMed PMID: 23441393.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. JuilletY, VlastoAP. Counterfeiting of medicinal drugs: issues and threats. Fundam Clin Pharmacol. 2005 Dec;19(6):621-4. Přejít k původnímu zdroji... Přejít na PubMed...
    2. Larkin M. Combating counterfeit drugs online. Lancet Infect Dis. 2006;6(9):552. doi:10.1016/S1473-3099(06)70573-4. Přejít k původnímu zdroji...
    3. EurActiv. MEPs approve laws to curb counterfeit drugs [Internet]. Euractiv; 2011 [cited 2012 May 14]. Available from: http://www.euractiv.com/health/meps-approve-laws-curb-counterfeit-drugs-news-502192.
    4. World Health Organization. Medicines. General information on counterfeit medicines [Internet]. Geneva: WHO; 2012 [cited 2012 May 14]. Available from: http://www.who.int/medicines/services/counterfeit/overview/en/.
    5. Wertheimer AI, Santella TM. Counterfeit drugs: defining the problem and finding solutions. Expert Opin Drug Saf. 2005 Jul;4(4):619-22. Přejít k původnímu zdroji... Přejít na PubMed...
    6. Gibson L. Drug regulators study global treaty to tackle counterfeit drugs. BMJ. 2004 Feb 28;328(7438):486. Přejít k původnímu zdroji... Přejít na PubMed...
    7. Rudolf PM, Bernstein IBG. Counterfeit drugs. N Engl J Med. 2004 Apr 1;350(14):1384-6. Přejít k původnímu zdroji... Přejít na PubMed...
    8. Zarocostas J. WHO to set up international task force on counterfeit drugs. BMJ. 2006 Feb 25;332(7539):444. Přejít k původnímu zdroji... Přejít na PubMed...
    9. Cassels A. Institute of Medicine's new drug safety report: implications for Canada. CMAJ. 2006 Dec 5;175(12):1515-6. Přejít k původnímu zdroji... Přejít na PubMed...
    10. European Commission. Taxation and customs union. Facts and figures [Internet]. Brussels: European Commission; 2012 [cited 2012 May 14]. Available from: http://ec.europa.eu/taxation_customs/customs/customs_controls/counterfeit_piracy/statistics/.
    11. Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, et al. Fake artesunate in southeastAsia. Lancet. 2001 Jun 16;357(9272):194850. Přejít k původnímu zdroji... Přejít na PubMed...
    12. Petrova GI. Monitoring of national drug policies - regional comparison between Bulgaria, Romania, Macedonia, Bosnia Herzegovina. Cent Eur J Public Health. 2001 Nov;9(4):205-13.
    13. Master Page. News about Poland - the Polish Outlook. Poland targeted by internet Viagra scammers [Internet]. [cited 2012 May 14]. Available from: http://www.masterpage.com.pl/outlook/200609/drugscam.html.
    14. Ahmad K. WHO fights fake pharmaceuticals. Lancet Infect Dis. 2006;6(4):195. Přejít k původnímu zdroji...
    15. Combating counterfeit drugs. Lancet. 2008;371(9624):1551. doi:10.1016/S0140-6736(08)60663-7. Přejít k původnímu zdroji... Přejít na PubMed...
    16. World Health Organization. Counterfeit drugs: guidelines for the development of measures to combat counterfeit drugs. Geneva: WHO; 1999.

    Zpět na obsah